Antimineralocorticoids offer no benefit in heart attack patients without heart failure
Heart attack patients without heart failure derive no benefit from the addition of mineralocortoid receptor antagonists (MRA), to standard therapy, results of the ALBATROSS study show.
Aug 30, 2015
0
4